THE PRINCIPLES OF CHEMOTHERAPY
By C. A. KEELE, M.D., F.R.C.P.
Reader in Pharmacology and Therapeutics, Middlesex Hospital Medical School This introduction to the collected articles on chemotherapy which have appeared recently in the POSTGRADUATE MEDICAL JOURNAL, is intended to deal only with general aspects of the subject. Some of the principles will doubtless appear very obvious, but there is perhaps no harm in repetition concerning such an important branch of medical science. No references to the literature are given here as they are provided by individual authors in their articles.
As in the therapeutic use of any drug, there is really only one aim in chemotherapy, namely, to choose the appropriate drug for the purpose and to administer it in such a way and for such time as are necessary for it to bring about the desired actions without producing unwanted side-effects.
Selection of the Appropriate Drug
In selecting drugs for the treatment of infections due to invading parasites the guiding principle is ' selective toxicity,' which means that one wants to choose drugs which are maximally harmful to the parasite and at the same time minimally harmful to the infected patient. This factor, first so clearly enunciated by Ehrlich, is fundamental in selecting new chemical substances for therapeutic use. Innumerable compounds which can kill off parasites in vitro are of no therapeutic value because effective parasiticidal doses are also toxic to the cells of the host.
Thus advances in chemotherapy depend on the discovery of drugs which are increasingly selective in poisoning pathogenic parasites. Consider the case of syphilis. Mercury, which was used from early in the Isth century until quite recently, had little if any spirochaeticidal action and readily produced toxic actions; the organic arsenicals, introduced by Ehrlich, are very potent spirochaeticidal agents but are sometimes rather toxic to the patient; bismuth is less toxic than the arsenicals, but has a weaker, though more prolonged, action on the Treponema pallidum. However, the combined arsenical-bismuth treatment was undoubtedly an effective regime with a cure rate of about 90 per cent. in patients with early syphilis who completed the long course of treatment. But the position has now been radically changed, and, as Dr. R. R. Willcox has stated, penicillin is now first choice for the treatment of all stages of syphilis. It may not be quite so toxic to the spirochaete as the organic arsenicals, but it is far less harmful to the infected patient. Its favourable ' therapeutic ratio ' (the minimum dose which produces toxic effects/the dose which produces a full therapeutic effect) means that penicillin may be given in curative doses with far less likelihood of serious toxic complications.
In some instances it is important to remember that the various stages of development of a parasite are differentially affected by drugs and Prof. Murgatroyd has discussed this question in relation to the treatment of malaria. The actions of proguanil (paludrine) on the pre-erythrocytic parasites of certain striins of P. falciparum; the schizonticidal actions of quinine, mepacrine, chloroquine and proguanil, and the gametocidal actions of pamaquine and pentaquine illustrate such differences in sensitivity to drugs of the different stages of the malarial parasite. In amoebic dysentery, too, the choice of drug depends on the phase of infection. As Dr. Adams points out, emetine hydrochloride is still best for the treatment of the acute attack or complications, whereas there are many drugs, including aureomycin, which may help in the control of chronic amoebiasis.
One 
Combined Chemotherapy
The question as to whether two drugs are better than one is obviously important. In some instances a combined attack is useful; for example, in pneumococcal meningitis the administration of sulphonamides to reach the infected area via the blood stream plus intrathecal penicillin gives better results than follow the use of either drug alone. Penicillin and streptomycin, which both have bactericidal actions, may also act synergistically on organisms susceptible to both; the conjoint actions of streptomycin and p-aminosalicylic acid in tuberculosis, and the combined effects of quinine and pamaquin in the radical cure of benign tertian malaria also illustrate the same point.
However, as Dr. Brownlee has described, there is experimental evidence to show that antibiotics may actually antagonize each other. For example, a bacteriostatic substance such as aureomycin may reduce the effectiveness of penicillin. The suggested explanation is that penicillin is bactericidal and acts best on rapidly multiplying organisms; if the bacterial metabolism is depressed by bacteriostatic agents the rate of multiplication is slowed and the effectiveness of penicillin is thereby decreased. It is not established that such an action would occur in human infections, but it is certainly best not to give more -than one antibiotic at a time.
Cost of Chemotherapy
The striking differences in the cost of treatment with the various drugs have been well stressed by Drs. Joules, Kilpatrick and Maclean. It is most desirable that adequate therapeutic trials should be done to establish the relative merits of the cheaply produced sulphonamides and the expensive newer antibiotics in the treatment of infections susceptible to both groups of drugs.
Administration and Dosage
To produce its actions a drug must gain access to those parts of the body where its effects are required. In most instances we rely on the bloodstream to distribute drugs in the body, but in others we apply drugs directly to the desired site of action. Thus the problems of administration and dosage depend ultimately on factors such as the absorption of the drug from the alimentary tract or site of injection, its distribution in the blood and body fluids, its diffusion into body cells, the metabolic changes undergone by the drug and, finally, The high blood levels which follow intravenous injection of a drug may sometimes be toxic to the heart. Emetine, which may cause cardiac arrhythymias and other signs of cardiac damage, should therefore never be given by this route. Intravenous administration is sometimes very wasteful, as in the case of drugs which are excreted rapidly via the kidney, and for this reason penicillin is not so given today.
Distribution
The Metabolic breakdown products of drugs are usually therapeutically inactive, but sometimes they may be toxic. The well-known insolubility of certain acetylated sulphonamides will be recalled in this connection.
Excretion
Most chemotherapeutic drugs appear in the bodily secretions. Their presence in bile might 'lead one to suppose that they would be effective in the treatment of biliary tract infections; unfortunately this is usually not the case as any infection which damages the liver greatly reduces the concentration of drug in the bile.
Excretion is mostly via the kidney and the concentration of drug in the urine greatly exceeds the blood level. This means that even though the drug be largely inactivated in the body (e.g. chloramphenicol and aureomycin), effective antibacterial concentration still occur in the urine. Moreover, in the case of penicillin which is excreted mainly by the renal tubules, the rate of excretion can be greatly decreased by certain subtances which selectively depress renal tubular function (caronamide, benemid). In this way higher blood penicillin levels can be attained.
It is often said that owing to the high concentrations which appear in the urine, sulphonamides may be given in smaller doses for the treatment of urinary tract infections. However, since the infection is often a pyelonephritis some of the organisms are only accessible via the blood stream, so that ordinary dosage might be required.
Dosage
The principles of dosage are simple enough. First a large loading dose is required to produce an adequate drug concentration in blood and body fluids as soon as possible, and this is followed by smaller maintenance doses at such intervals as will sustain the required levels until the infection is brought under control. In nearly all cases the drug should be stopped when the temperature has been normal for three days, and usually treatment with these drugs should not exceed a week. If administration is prolonged the incidence of toxic effects is greatly increased, and the development of drug resistant organisms might occur.
Toxic Effects
The parasiticidal action of drugs cannot be expected to be so specific that no harm whatever is done to the host. It is always a question of the margin between the therapeutic and toxic doses, and in some cases this is very small, or the therapeutic and toxic ranges may even overlap. At the present day, when there may be several drugs which can kill off a particular organism, the most valuable will clearly be the least toxic member of the series. For this reason penicillin has replaced the organic arsenicals in the treatment of syphilis, and the older sulphonamides, e.g. sulphapyridrine, have been supplanted by compounds such as sulphamerazine and sulphadimidine in the treatment of bacterial infections. Thus, many toxic actions may nowadays be avoided by using a more specific, less toxic compound and this is the first and most satisfactory way of tackling the problem of drug toxicity. Thus it is most important to take account of these sensitization reactions in assessing the significance of rashes or fever which develop during chemotherapy. If the fever due to the original infection has subsided and the patient has had a normal temperature for two days, a sudden rise of temperature might be due to a recrudescence of the infection, to drug fever or perhaps to agranulocytosis. It is important to consider this question carefully as the remedy for the two latter states is so simple.
Nowadays, when there is often a choice of drugs for the treatment of a particular infection, a patient who has becom sensitized to one drug should tolerate another. For example, a patient who has become sensitized to sulphonamide might well be sensitive to other drugs of this group. Thus, a patient known to be sensitive to a drug, even though it be the first choice for a particular infection, should be treated with a drug belonging to a different chemical group. This is one of the great advantages of having more than one drug for the treatment of a given infection.
Disturbances in Baoterial Flora
Among the toxic effects which sometimes accompany chemotherapy are those which may be due to the indiscriminate destruction of commensals as well as pathogenic micro-organisms. It is sometimes desirable to sterilize the alimentary tract, as, for example, before operations on the bowel which might contaminate the peritoneum, but there is evidence which suggests that glossitis, angular stomatitis, and inflammation in the rectum and vagina, may often be due to the upheaval in bacterial ecology produced by chemotherapy; this leads to the unusual predominance of such insensitive ,organisms as B. coli and monilia such as Candida albicans. Some of the changes, e.g. angular stomatitis have been attributed to deficiency of vitamin B complex, e.g. ariboflavinosis, but administration of vitamin B does not always prevent or relieve these complications, and the abnormal flora might well act directly to cause such changes.
The flatulence and looseness of the bowels which occur with chloramphenicol and aureomycin may also be due to alterations in the flora of the alimentary tract, but direct irritation by the drugs might sometimes cause diarrhoea in the same way as it may produce vomiting.
The future of chemotherapy is difflcult to forecast, but some of the long-term problems are beginning to be revealed. The gradual development of drug-resistance of certain bacterial ,7une 1952 species is a striking illustration of the adaptive power of living organisms to their environment and how far this process will eventually nullify the benefits which chemotherapy has provided, or how far the dislocations of bacterial ecology will perhaps prove harmful to man, are questions which no one can answer. On the hopeful side there are of course the possibilities of gaining control of infections due to viruses and a beginning has been made in this field with the introduction of chloramphenicol and aureomycin.
In conclusion, one might recall how all the fundamental factors involved in modern chemotherapy were outlined, and in many cases thoroughly studied, 'by Ehrlich in the early years *of this century. His practical achievements were perhaps less important than his establishment of the principles of the subject. His ' chemoreceptor' theory, with the recognition of ' parasitotropic ' 
